Related Experiment Video
Updated: Jan 25, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Shifting Gears: The Future of Polymyxin Antibiotics
Justin R Lenhard1, Zackery P Bulman2, Brian T Tsuji3
1Department of Clinical and Administrative Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USA. Justin.lenhard@cnsu.edu.
Abstract:
The manuscripts contained in this special edition of Antibiotics represent a current review of the polymyxins as well as highlights from the 3rd International Polymyxin Conference, which was held in Madrid, Spain, April 25 to 26, 2018. The role of the polymyxin antibiotics has evolved over time based on the availability of alternative agents. After high rates of nephrotoxicity caused the drug class to fall out of favor, polymyxins were once against utilized in the 21st century to combat drug-resistant pathogens. However, the introduction of safer agents with activity against drug-resistant organisms has brought the future utility of polymyxins into question. The present review investigates the future niche of polymyxins by evaluating currently available and future treatment options for difficult-to-treat pathogens. The introduction of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin are likely to decrease polymyxin utilization for infections caused by Enterobacteriaceae. Similarly, the availability of ceftolozane-tazobactam will reduce the use of polymyxins to counter multidrug-resistant Pseudomonas aeruginosa. In contrast, polymyxins will likely continue be an important option for combatting carbapenem-resistant Acinetobacter baumannii until better options become commercially available. Measuring polymyxin concentrations in patients and individualizing therapy may be a future strategy to optimize clinical outcomes while minimizing nephrotoxicity. Inhaled polymyxins will continue to be an adjunctive option for pulmonary infections but further clinical trials are needed to clarify the efficacy of inhaled polymyxins. Lastly, safer polymyxin analogs will potentially be an important addition to the antimicrobial armamentarium.
Insights
Polymyxin antibiotics are regaining use against resistant bacteria but face competition from new drugs. Future use may focus on specific infections like carbapenem-resistant Acinetobacter baumannii, with personalized dosing and new analogs offering promise.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Polymyxin antibiotics, once sidelined due to nephrotoxicity, have seen a resurgence for treating multidrug-resistant pathogens.
- The evolving landscape of antimicrobial agents necessitates a re-evaluation of polymyxins' role.
Purpose of the Study:
- To review the current status and future prospects of polymyxin antibiotics.
- To evaluate treatment options for difficult-to-treat bacterial infections in light of new antimicrobial developments.
Main Methods:
- Review of current literature and highlights from the 3rd International Polymyxin Conference.
- Analysis of the impact of newly introduced antibiotics on polymyxin utilization.
Main Results:
- New agents like ceftazidime-avibactam and ceftolozane-tazobactam are expected to reduce polymyxin use against Enterobacteriaceae and Pseudomonas aeruginosa.
- Polymyxins remain crucial for carbapenem-resistant Acinetobacter baumannii infections pending alternative treatments.
- Inhaled polymyxins show potential as adjunctive therapy for pulmonary infections, requiring further clinical validation.
Conclusions:
- The niche for polymyxins is narrowing due to newer, safer antibiotics.
- Personalized dosing and development of safer polymyxin analogs are key strategies for optimizing future use.
- Polymyxins will likely retain importance for specific resistant infections, particularly Acinetobacter baumannii.
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
NMR Spectroscopy: Chemical Shift Overview
For instance, the proton...
Proton (¹H) NMR: Chemical Shift
Absorption signals of all the protium nuclei...
Chemical Shift: Internal References and Solvent Effects
The internal reference compound generally used in NMR spectroscopy is tetramethylsilane (TMS). TMS is preferred because it is chemically inert, soluble in NMR solvents, and easily removable. Also, the highly shielded methyl protons in TMS yield an intense...
π Electron Effects on Chemical Shift: Overview

